Benzinga Blog | Talkmarkets | Page 1
Financial News
Contributor's Links: Benzinga

Benzinga is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street's top traders. Benzinga provides timely, actionable ideas that help users navigate even the most uncertain and volatile markets – in ... more

All Contributions

Latest Posts
1 to 16 of 1533 Posts
1 2 3 ... 96
A Bull Vs. Bear Debate On Nikola Following Milton's Resignation
Investors must now decide if the Nikola Corporation fraud allegations and the departure of chairman Trevor Milton is a long-term buying opportunity or if the worst is yet to come for the stock.
Bulls And Bears Of The Week: Chevron, Oracle, Twitter And More
Here are a few of this past week's most bullish and bearish posts that are worth another look.
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Biotech stocks reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson kickstarting a Phase 3 trial of its coronavirus vaccine candidate.
Here's Where The S&P 500 Could Be In 20 Years
This year has been an extremely volatile year on Wall Street, but the S&P 500 has made very little progress one way or the other year to date. In fact, the SPDR S&P 500 ETF Trust SPY is up just 0.7% overall as 2020 is heading into the fourth quarter.
Lighten Up On FAANG With This Nifty Nasdaq ETF
Some investors may look to defray the concentration risk with the Direxion Nasdaq-100 Equal Weighted Index Shares, QQQE.
Moderna Will Start To Outrun Coronavirus Competition In 2021, Analyst Says
Oppenheimer analyst Hartaj Singh maintained an Outperform rating and a $108 price target.
The Street Debates Whether Costco Investors Should Buy The Dip
Costco Wholesale Corporation reported a top-and-bottom line beat in the fourth quarter, but shares moved lower following the earnings release Thursday afternoon. Here's how the Street reacted.
Exxon Mobil's Dividend Yield Hits 10%: What Investors Need To Know
Exxon Mobil's dividend yield has continued to rise in a year that the stock has fallen by more than 50%. 
Electric Vehicle ETF In Reverse Spells Opportunity
To say this has been a big week for electric vehicle stocks and the related exchange-traded funds is an understatement.
FDA Vaccine Committee Head Steps Aside Over Conflict Of Interest With Moderna Role
The head of the United States FDA’s vaccine advisory committee has recused herself from the panel due to her involvement in supervising the clinical trial of Moderna Inc’s COVID-19 vaccine.
Nike Analysts Bullish Following Earnings Beat: 'Long-Awaited, Structurally Higher Margins'
Bank of America analyst Robert Ohmes said investors should expect a strong second half of fiscal 2021 from Nike as the company continues to gain global market share.
4 Stitch Fix Analysts Unpack Q4 Report As Stock Plunges
Online personal styling company Stitch Fix Inc SFIX reported Tuesday afternoon. Here's how the Street reacted. 
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021
Johnson & Johnson has joined the big league of frontrunners in the coronavirus vaccine race following its announcement concerning the initiation of the Phase 3 study.
Facebook Removes Chinese Propaganda Network Trying To Influence US Presidential Election
Facebook said Tuesday it removed a network of fake accounts that spread propaganda and disinformation on China’s claims over the South China Sea and surrounding geography in the United States and Southeast Asia.
GoodRx Holdings IPO: What Investors Need To Know
Prescription pricing platform GoodRx Holdings will hit the public markets this week.
KB Home: Q3 Earnings Insights
Earnings per share were up 13.70% year over year to $0.83, which beat the estimate of $0.54.
1 to 16 of 1533 Posts
1 2 3 ... 96